In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa
Katherine Young(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mary Motyl(Merck & Co., Inc., Rahway, NJ, USA (United States)), Fred Racine(Merck & Co., Inc., Rahway, NJ, USA (United States)), Carl J. Balibar(Merck & Co., Inc., Rahway, NJ, USA (United States)), Artjohn Villafania(Merck & Co., Inc., Rahway, NJ, USA (United States)), Timothy A. Blizzard(Merck & Co., Inc., Rahway, NJ, USA (United States)), Rumin Zhang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nichelle Hairston(Merck & Co., Inc., Rahway, NJ, USA (United States)), Milton L. Hammond(Merck & Co., Inc., Rahway, NJ, USA (United States)), Douglas Wisniewski(Merck & Co., Inc., Rahway, NJ, USA (United States)), Susan L. Raghoobar(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ronald E. Painter(Merck & Co., Inc., Rahway, NJ, USA (United States)), Daniel F. Sahm(Micro Focus (United States)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 126
Related Papers
Prevalence in the United States of <i>aac(6</i> ′ <i>)</i> - <i>Ib</i> - <i>cr</i> Encoding a Ciprofloxacin-Modifying Enzyme
|Antimicrobial Agents and Chemotherapy|2006|749
Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future
|Emerging infectious diseases|1998|732
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419